LOPINAVIR\RITONAVIR for Prophylaxis against hiv infection: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 86 adverse event reports in the FDA FAERS database where LOPINAVIR\RITONAVIR was used for Prophylaxis against hiv infection.
Most Reported Side Effects for LOPINAVIR\RITONAVIR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 2,010 | 24.2% | 370 | 798 |
| Foetal exposure during pregnancy | 932 | 11.2% | 147 | 101 |
| Drug interaction | 821 | 9.9% | 189 | 233 |
| Depression | 551 | 6.6% | 135 | 98 |
| Virologic failure | 428 | 5.2% | 20 | 33 |
| Exposure during pregnancy | 395 | 4.8% | 36 | 71 |
| Diarrhoea | 363 | 4.4% | 38 | 148 |
| Maternal exposure during pregnancy | 311 | 3.8% | 31 | 71 |
| Product use in unapproved indication | 282 | 3.4% | 76 | 135 |
| Nausea | 243 | 2.9% | 9 | 83 |
| Pathogen resistance | 234 | 2.8% | 16 | 25 |
| Lipodystrophy acquired | 230 | 2.8% | 0 | 16 |
| Acute kidney injury | 226 | 2.7% | 38 | 96 |
| Drug ineffective | 220 | 2.7% | 30 | 81 |
| Drug resistance | 220 | 2.7% | 19 | 44 |
Other Indications for LOPINAVIR\RITONAVIR
Hiv infection (3,387)
Covid-19 (1,549)
Product used for unknown indication (840)
Covid-19 pneumonia (727)
Coronavirus infection (388)
Antiretroviral therapy (376)
Maternal exposure timing unspecified (278)
Acquired immunodeficiency syndrome (125)
Antiviral treatment (89)
Hepatitis c (76)
Other Drugs Used for Prophylaxis against hiv infection
EMTRICITABINE\TENOFOVIR DISOPROXIL (5,005)
NEVIRAPINE (828)
EMTRICITABINE\TENOFOVIR ALAFENAMIDE (695)
CABOTEGRAVIR (692)
EMTRICITABINE\TENOFOVIR (635)
ZIDOVUDINE (571)
LAMIVUDINE (319)
EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (304)
RITONAVIR (171)
EMTRICITABINE (167)